{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T03:06:17Z","timestamp":1791515177518,"version":"4.3.4"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,11,3]],"date-time":"2023-11-03T00:00:00Z","timestamp":1698969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,11,3]],"date-time":"2023-11-03T00:00:00Z","timestamp":1698969600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"The Affiliated Hospital of Xuzhou Medical University","award":["2021104605"],"award-info":[{"award-number":["2021104605"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Lipids Health Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>The elevation of TyG is considered an important factor in promoting the progression of non-alcoholic fatty liver disease (NAFLD), but its impact on the degree of liver steatosis remains unclear. This study aims to explore the relationship between TyG and TyG-related indices, such as triglyceride glucose-body mass index (TyG-BMI), with the degree of liver fat accumulation.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>From January 2021 to March 2022, 1171 participants underwent health check-ups, and all underwent FibroScan transient elastography. The analysis focused on identifying the factors that contribute to the onset of NAFLD and the degree of hepatic steatosis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      The predictive value of TyG-BMI (OR\u2009=\u20091.039, 95% CI 1.031\u20131.046) in triggering NAFLD development was greater than that of TyG alone. The areas under the curve for TyG-BMI and TyG were calculated at 0.808 and 0.720, respectively. TyG-BMI (OR\u2009=\u20091.034,\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&lt;\u20090.001) was identified as a main independent factor affecting hepatic steatosis severity. With each incremental increase in TyG-BMI, the likelihood of experiencing an increase in the extent of hepatic steatosis was 1.034 times higher than that of the preceding unit.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>The TyG-BMI showed higher accuracy in predicting NAFLD than did the TyG, and was more closely linked to the severity of hepatic steatosis. Therefore, it can be included as a parameter in health management centers and should be widely used to screen and evaluate patients with NAFLD.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12944-023-01954-5","type":"journal-article","created":{"date-parts":[[2023,11,3]],"date-time":"2023-11-03T06:02:35Z","timestamp":1698991355000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":34,"title":["Application value of triglyceride-glucose index and triglyceride-glucose body mass index in evaluating the degree of hepatic steatosis in non-alcoholic fatty liver disease"],"prefix":"10.1186","volume":"22","author":[{"given":"Mengyuan","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingxing","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peipu","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huayao","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guifang","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,11,3]]},"reference":[{"key":"1954_CR1","doi-asserted-by":"publisher","first-page":"1497","DOI":"10.1111\/jgh.15353","volume":"36","author":"M Ahadi","year":"2021","unstructured":"Ahadi M, Molooghi K, Masoudifar N, Namdar AB, Vossoughinia H, Farzanehfar M. A review of non-alcoholic fatty liver disease in non-obese and lean individuals. J Gastroenterol Hepatol. 2021;36:1497\u2013507. https:\/\/doi.org\/10.1111\/jgh.15353.","journal-title":"J Gastroenterol Hepatol"},{"key":"1954_CR2","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1038\/s41575-021-00523-4","volume":"19","author":"J Lazarus","year":"2022","unstructured":"Lazarus J, Mark H, Anstee Q, Arab J, Batterham R, Castera L, Cortez-Pinto H, Crespo J, Cusi K, Dirac M, et al. Advancing the global public health agenda for NAFLD: a consensus statement. Nat Rev Gastroenterol Hepatol. 2022;19:60\u201378. https:\/\/doi.org\/10.1038\/s41575-021-00523-4.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"1954_CR3","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1016\/j.clnesp.2021.04.025","volume":"44","author":"H Tutunchi","year":"2021","unstructured":"Tutunchi H, Naeini F, Mobasseri M, Ostadrahimi A. Triglyceride glucose (TyG) index and the progression of liver fibrosis: A cross-sectional study. Clin Nutr ESPEN. 2021;44:483\u20137. https:\/\/doi.org\/10.1016\/j.clnesp.2021.04.025.","journal-title":"Clin Nutr ESPEN"},{"key":"1954_CR4","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1016\/j.jcmgh.2021.12.008","volume":"13","author":"F Luo","year":"2022","unstructured":"Luo F, Smagris E, Martin S, Vale G, McDonald J, Fletcher J, Burgess S, Hobbs H, Cohen J. Hepatic TM6SF2 Is Required for Lipidation of VLDL in a Pre-Golgi Compartment in Mice and Rats. Cell Mol Gastroenterol Hepatol. 2022;13:879\u201399. https:\/\/doi.org\/10.1016\/j.jcmgh.2021.12.008.","journal-title":"Cell Mol Gastroenterol Hepatol"},{"key":"1954_CR5","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1002\/hep4.1822","volume":"6","author":"F Luo","year":"2022","unstructured":"Luo F, Oldoni F, Das A. TM6SF2: A Novel Genetic Player in Nonalcoholic Fatty Liver and Cardiovascular Disease. Hepatol Commun. 2022;6:448\u201360. https:\/\/doi.org\/10.1002\/hep4.1822.","journal-title":"Hepatol Commun"},{"key":"1954_CR6","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.1210\/er.2019-00034","volume":"40","author":"M Watt","year":"2019","unstructured":"Watt M, Miotto P, De Nardo W, Montgomery M. The Liver as an Endocrine Organ-Linking NAFLD and Insulin Resistance. Endocr Rev. 2019;40:1367\u201393. https:\/\/doi.org\/10.1210\/er.2019-00034.","journal-title":"Endocr Rev"},{"key":"1954_CR7","doi-asserted-by":"publisher","unstructured":"Zhang S, Du T, Zhang J, Lu H, Lin X, Xie J, Yang Y, Yu X: The triglyceride and glucose index (TyG) is an effective biomarker to identify nonalcoholic fatty liver disease. Lipids in Health and Disease 2017, 16.https:\/\/doi.org\/10.1186\/s12944-017-0409-6","DOI":"10.1186\/s12944-017-0409-6"},{"key":"1954_CR8","doi-asserted-by":"publisher","first-page":"2537","DOI":"10.1016\/j.cell.2021.04.015","volume":"184","author":"R Loomba","year":"2021","unstructured":"Loomba R, Friedman SL, Shulman GI. Mechanisms and disease consequences of nonalcoholic fatty liver disease. Cell. 2021;184:2537\u201364. https:\/\/doi.org\/10.1016\/j.cell.2021.04.015.","journal-title":"Cell"},{"key":"1954_CR9","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1007\/s00018-018-2947-0","volume":"76","author":"F Bessone","year":"2019","unstructured":"Bessone F, Razori MV, Roma MG. Molecular pathways of nonalcoholic fatty liver disease development and progression. Cell Mol Life Sci. 2019;76:99\u2013128. https:\/\/doi.org\/10.1007\/s00018-018-2947-0.","journal-title":"Cell Mol Life Sci"},{"key":"1954_CR10","doi-asserted-by":"publisher","first-page":"2829","DOI":"10.2147\/DMSO.S316864","volume":"14","author":"J Liu","year":"2021","unstructured":"Liu J, Guan L, Zhao M, Li Q, Song A, Gao L, Lin H, Zhao J. Association Between the Triglyceride-Glucose Index and Outcomes of Nonalcoholic Fatty Liver Disease: A Large-Scale Health Management Cohort Study. Diabetes Metab Syndr Obes. 2021;14:2829\u201339. https:\/\/doi.org\/10.2147\/DMSO.S316864.","journal-title":"Diabetes Metab Syndr Obes"},{"key":"1954_CR11","doi-asserted-by":"publisher","first-page":"179","DOI":"10.3803\/EnM.2019.34.2.179","volume":"34","author":"SB Lee","year":"2019","unstructured":"Lee SB, Kim MK, Kang S, Park K, Kim JH, Baik SJ, Nam JS, Ahn CW, Park JS. Triglyceride Glucose Index Is Superior to the Homeostasis Model Assessment of Insulin Resistance for Predicting Nonalcoholic Fatty Liver Disease in Korean Adults. Endocrinol Metab (Seoul). 2019;34:179\u201386. https:\/\/doi.org\/10.3803\/EnM.2019.34.2.179.","journal-title":"Endocrinol Metab (Seoul)"},{"key":"1954_CR12","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1186\/s12944-021-01506-9","volume":"20","author":"R Wang","year":"2021","unstructured":"Wang R, Dai L, Zhong Y, Xie G. Usefulness of the triglyceride glucose-body mass index in evaluating nonalcoholic fatty liver disease: insights from a general population. Lipids Health Dis. 2021;20:77. https:\/\/doi.org\/10.1186\/s12944-021-01506-9.","journal-title":"Lipids Health Dis"},{"key":"1954_CR13","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1089\/met.2020.0109","volume":"19","author":"ME Khamseh","year":"2021","unstructured":"Khamseh ME, Malek M, Abbasi R, Taheri H, Lahouti M, Alaei-Shahmiri F. Triglyceride Glucose Index and Related Parameters (Triglyceride Glucose-Body Mass Index and Triglyceride Glucose-Waist Circumference) Identify Nonalcoholic Fatty Liver and Liver Fibrosis in Individuals with Overweight\/Obesity. Metab Syndr Relat Disord. 2021;19:167\u201373. https:\/\/doi.org\/10.1089\/met.2020.0109.","journal-title":"Metab Syndr Relat Disord"},{"key":"1954_CR14","doi-asserted-by":"publisher","first-page":"101580","DOI":"10.1016\/j.clinre.2020.11.010","volume":"45","author":"Magalhaes R de Sousa","year":"2021","unstructured":"de Sousa Magalhaes R, Xavier S, Magalhaes J, Rosa B, Marinho C, Cotter J. Transient elastography through controlled attenuated parameter assisting the stratification of cardiovascular disease risk in NAFLD patients. Clin Res Hepatol Gastroenterol. 2021;45:101580. https:\/\/doi.org\/10.1016\/j.clinre.2020.11.010.","journal-title":"Clin Res Hepatol Gastroenterol"},{"key":"1954_CR15","doi-asserted-by":"publisher","first-page":"910","DOI":"10.1016\/j.dld.2017.03.013","volume":"49","author":"L Xu","year":"2017","unstructured":"Xu L, Lu W, Li P, Shen F, Mi YQ, Fan JG. A comparison of hepatic steatosis index, controlled attenuation parameter and ultrasound as noninvasive diagnostic tools for steatosis in chronic hepatitis B. Dig Liver Dis. 2017;49:910\u20137. https:\/\/doi.org\/10.1016\/j.dld.2017.03.013.","journal-title":"Dig Liver Dis"},{"key":"1954_CR16","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1093\/gastro\/got007","volume":"1","author":"GL Wong","year":"2013","unstructured":"Wong GL. Update of liver fibrosis and steatosis with transient elastography (Fibroscan). Gastroenterol Rep (Oxf). 2013;1:19\u201326. https:\/\/doi.org\/10.1093\/gastro\/got007.","journal-title":"Gastroenterol Rep (Oxf)"},{"key":"1954_CR17","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1002\/hep.31220","volume":"73","author":"B Zhou","year":"2021","unstructured":"Zhou B, Liu C, Xu L, Yuan Y, Zhao J, Zhao W, Chen Y, Qiu J, Meng M, Zheng Y, et al. N(6) -Methyladenosine Reader Protein YT521-B Homology Domain-Containing 2 Suppresses Liver Steatosis by Regulation of mRNA Stability of Lipogenic Genes. Hepatology. 2021;73:91\u2013103. https:\/\/doi.org\/10.1002\/hep.31220.","journal-title":"Hepatology"},{"key":"1954_CR18","doi-asserted-by":"publisher","first-page":"1596","DOI":"10.1038\/s42255-021-00501-9","volume":"3","author":"H Tilg","year":"2021","unstructured":"Tilg H, Adolph TE, Dudek M, Knolle P. Non-alcoholic fatty liver disease: the interplay between metabolism, microbes and immunity. Nat Metab. 2021;3:1596\u2013607. https:\/\/doi.org\/10.1038\/s42255-021-00501-9.","journal-title":"Nat Metab"},{"key":"1954_CR19","doi-asserted-by":"publisher","first-page":"110733","DOI":"10.1016\/j.diabres.2023.110733","volume":"201","author":"J Chen","year":"2023","unstructured":"Chen J, Su Y, Su X, Luo F. Remnant cholesterol has a non-linear association with non-alcoholic fatty liver disease. Diabetes Res Clin Pract. 2023;201:110733. https:\/\/doi.org\/10.1016\/j.diabres.2023.110733.","journal-title":"Diabetes Res Clin Pract"},{"key":"1954_CR20","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1186\/s12944-021-01561-2","volume":"20","author":"G Sheng","year":"2021","unstructured":"Sheng G, Lu S, Xie Q, Peng N, Kuang M, Zou Y. The usefulness of obesity and lipid-related indices to predict the presence of Non-alcoholic fatty liver disease. Lipids Health Dis. 2021;20:134. https:\/\/doi.org\/10.1186\/s12944-021-01561-2.","journal-title":"Lipids Health Dis"},{"key":"1954_CR21","doi-asserted-by":"publisher","first-page":"475","DOI":"10.47162\/RJME.62.2.13","volume":"62","author":"AM Amzolini","year":"2021","unstructured":"Amzolini AM, Fortofoiu MC, Barau Abu-Alhija A, Vladu IM, Clenciu D, Mitrea A, Fortofoiu M, Matei D, Enachescu V, Predescu OI, Micu ES. Triglyceride and glucose index: a useful tool for non-alcoholic liver disease assessed by liver biopsy in patients with metabolic syndrome? Rom J Morphol Embryol. 2021;62:475\u201380. https:\/\/doi.org\/10.47162\/RJME.62.2.13.","journal-title":"Rom J Morphol Embryol"},{"key":"1954_CR22","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1186\/s12944-021-01560-3","volume":"20","author":"F Xie","year":"2021","unstructured":"Xie F, Pei Y, Zhou Q, Cao D, Wang Y. Comparison of obesity-related indices for identifying nonalcoholic fatty liver disease: a population-based cross-sectional study in China. Lipids Health Dis. 2021;20:132. https:\/\/doi.org\/10.1186\/s12944-021-01560-3.","journal-title":"Lipids Health Dis"},{"key":"1954_CR23","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/j.jhep.2015.04.006","volume":"63","author":"European Association for Study of L","year":"2015","unstructured":"European Association for Study of L, Asociacion Latinoamericana para el Estudio del H. EASL-ALEH Clinical Practice Guidelines: Non-invasive tests for evaluation of liver disease severity and prognosis. J Hepatol. 2015;63:237\u201364. https:\/\/doi.org\/10.1016\/j.jhep.2015.04.006.","journal-title":"J Hepatol"},{"key":"1954_CR24","doi-asserted-by":"publisher","first-page":"1536","DOI":"10.1053\/j.gastro.2017.03.017","volume":"152","author":"JK Lim","year":"2017","unstructured":"Lim JK, Flamm SL, Singh S, Falck-Ytter YT. Clinical Guidelines Committee of the American Gastroenterological A: American Gastroenterological Association Institute Guideline on the Role of Elastography in the Evaluation of Liver Fibrosis. Gastroenterology. 2017;152:1536\u201343. https:\/\/doi.org\/10.1053\/j.gastro.2017.03.017.","journal-title":"Gastroenterology"},{"key":"1954_CR25","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1186\/s12944-020-01393-6","volume":"19","author":"W Guo","year":"2020","unstructured":"Guo W, Lu J, Qin P, Li X, Zhu W, Wu J, Xu N, Zhang Q. The triglyceride-glucose index is associated with the severity of hepatic steatosis and the presence of liver fibrosis in non-alcoholic fatty liver disease: a cross-sectional study in Chinese adults. Lipids Health Dis. 2020;19:218. https:\/\/doi.org\/10.1186\/s12944-020-01393-6.","journal-title":"Lipids Health Dis"},{"key":"1954_CR26","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1038\/s41580-021-00390-6","volume":"22","author":"DE James","year":"2021","unstructured":"James DE, St\u00f6ckli J, Birnbaum MJ. The aetiology and molecular landscape of insulin resistance. Nat Rev Mol Cell Biol. 2021;22:751\u201371. https:\/\/doi.org\/10.1038\/s41580-021-00390-6.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"1954_CR27","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1186\/s12902-022-00993-w","volume":"22","author":"N Li","year":"2022","unstructured":"Li N, Tan H, Xie A, Li C, Fu X, Xang W, Kirim A, Huang X. Value of the triglyceride glucose index combined with body mass index in identifying non-alcoholic fatty liver disease in patients with type 2 diabetes. BMC Endocr Disord. 2022;22:101. https:\/\/doi.org\/10.1186\/s12902-022-00993-w.","journal-title":"BMC Endocr Disord"},{"key":"1954_CR28","doi-asserted-by":"publisher","unstructured":"Kim H, Cho Y, Kim E, Lee M, Jung C, Park J, Kim H, Lee W: Triglyceride Glucose-Waist Circumference Is Superior to the Homeostasis Model Assessment of Insulin Resistance in Identifying Nonalcoholic Fatty Liver Disease in Healthy Subjects. J Clin Med 2021, 11.https:\/\/doi.org\/10.3390\/jcm11010041","DOI":"10.3390\/jcm11010041"},{"key":"1954_CR29","doi-asserted-by":"publisher","first-page":"e0212963","DOI":"10.1371\/journal.pone.0212963","volume":"14","author":"J Lim","year":"2019","unstructured":"Lim J, Kim J, Koo SH, Kwon GC. Comparison of triglyceride glucose index, and related parameters to predict insulin resistance in Korean adults: An analysis of the 2007\u20132010 Korean National Health and Nutrition Examination Survey. PLoS One. 2019;14:e0212963. https:\/\/doi.org\/10.1371\/journal.pone.0212963.","journal-title":"PLoS One"},{"key":"1954_CR30","doi-asserted-by":"publisher","unstructured":"Li Y, Zheng R, Li J, Feng S, Wang L, Huang Z: Association between triglyceride glucose-body mass index and non-alcoholic fatty liver disease in the non-obese Chinese population with normal blood lipid levels: a secondary analysis based on a prospective cohort study. Lipids in Health and Disease 2020, 19.https:\/\/doi.org\/10.1186\/s12944-020-01409-1","DOI":"10.1186\/s12944-020-01409-1"},{"key":"1954_CR31","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1186\/s13098-020-00570-y","volume":"12","author":"AF Godoy-Matos","year":"2020","unstructured":"Godoy-Matos AF, Silva Junior WS, Valerio CM. NAFLD as a continuum: from obesity to metabolic syndrome and diabetes. Diabetol Metab Syndr. 2020;12:60. https:\/\/doi.org\/10.1186\/s13098-020-00570-y.","journal-title":"Diabetol Metab Syndr"},{"key":"1954_CR32","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.metabol.2018.11.014","volume":"92","author":"SA Polyzos","year":"2019","unstructured":"Polyzos SA, Kountouras J, Mantzoros CS. Obesity and nonalcoholic fatty liver disease: From pathophysiology to therapeutics. Metabolism. 2019;92:82\u201397. https:\/\/doi.org\/10.1016\/j.metabol.2018.11.014.","journal-title":"Metabolism"},{"key":"1954_CR33","doi-asserted-by":"publisher","unstructured":"Oral A, Sahin T, Turker F, Kocak E: Relationship Between Serum Uric Acid Levels and Nonalcoholic Fatty Liver Disease in Non-Obese Patients. Medicina (Kaunas) 2019, 55.https:\/\/doi.org\/10.3390\/medicina55090600","DOI":"10.3390\/medicina55090600"},{"key":"1954_CR34","doi-asserted-by":"publisher","first-page":"530","DOI":"10.4254\/wjh.v10.i8.530","volume":"10","author":"Q Li","year":"2018","unstructured":"Li Q, Dhyani M, Grajo J, Sirlin C, Samir A. Current status of imaging in nonalcoholic fatty liver disease. World J Hepatol. 2018;10:530\u201342. https:\/\/doi.org\/10.4254\/wjh.v10.i8.530.","journal-title":"World J Hepatol"}],"container-title":["Lipids in Health and Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12944-023-01954-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12944-023-01954-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12944-023-01954-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,3]],"date-time":"2023-11-03T06:04:43Z","timestamp":1698991483000},"score":1,"resource":{"primary":{"URL":"https:\/\/lipidworld.biomedcentral.com\/articles\/10.1186\/s12944-023-01954-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,3]]},"references-count":34,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["1954"],"URL":"https:\/\/doi.org\/10.1186\/s12944-023-01954-5","relation":{},"ISSN":["1476-511X"],"issn-type":[{"value":"1476-511X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,11,3]]},"assertion":[{"value":"7 August 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 October 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 November 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The ethical approval for this study was obtained from the Ethics Committee of the Affiliated Hospital of Xuzhou Medical University (XYFY2023-KL245-02).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"186"}}